Boston IVF AI Market Strategy Report - IVF Clinics

Answer Capsule

Boston IVF holds a narrow but real position in AI-generated recommendations for IVF clinics, with 3.63% valid recommendation coverage in September 2026. The brand appears in AI responses at a 6.34% presence rate, yet converts less than half of those mentions into actual recommendations. Boston IVF recorded its first rank-one recommendation of the benchmark series in September 2026, a signal that first-choice placement is possible even at low overall coverage. The clearest opportunity lies in converting existing neutral visibility into stronger recommendation placement, particularly on ChatGPT where the brand already achieves its highest positive visibility rate.

Who This Report Is For

This report is for marketing, growth, and patient acquisition leaders at Boston IVF who need to understand how AI search and chat platforms currently present the clinic to prospective patients researching fertility treatment options.

Report Card

Executive Summary

Boston IVF holds a modest but measurable position in AI-generated recommendations for IVF clinics. The September 2026 benchmark shows the clinic appearing in 21 qualified observations, with 12 positive mentions, 9 neutral mentions, and no negative framing across the tracked AI surfaces. That translates to a 6.34% raw mention presence rate and 3.63% valid recommendation coverage, placing Boston IVF eighth among the ten tracked brands.

The strongest platform signal comes from ChatGPT, where Boston IVF achieves a 10.53% positive visibility rate and records 4 valid recommendations from 4 mentions. This is the brand's highest conversion of presence into positive framing on any platform. The clearest gap appears on Gemini, where Boston IVF appears in 2 observations but receives no valid recommendation credit, and on Copilot, where the brand appears twice but earns only a single recommendation at rank seven.

Boston IVF's 3.63% valid recommendation coverage represents a steady three-month climb from 2.5% at the July 2026 baseline. The brand also recorded its first rank-one recommendation of the series in September 2026, appearing as the single top recommendation in one qualified observation. While the overall numbers remain small, the directional pattern is positive: Boston IVF is gaining recommendation coverage and placement quality even as its raw presence remains limited.

What Boston IVF Is Winning

Boston IVF shows a narrow but meaningful recommendation pocket on ChatGPT. The platform accounts for 4 of the brand's 12 valid recommendations, with a 10.53% valid recommendation coverage rate that is roughly three times the brand's overall average. All 4 ChatGPT mentions carry positive framing, giving Boston IVF a perfect sentiment score of 1.0 on that platform.

The brand also recorded its first rank-one recommendation of the benchmark series in September 2026. While this represents a single observation, it signals that AI systems are capable of placing Boston IVF as the first-choice option in at least some high-intent responses.

Boston IVF carries no negative framing across any tracked platform. Every mention in the September 2026 benchmark is either positive or neutral, which keeps the brand's net sentiment score at a healthy 0.5714 despite its low overall visibility.

Where Boston IVF Has the Clearest AI Visibility Gaps

Questions This Section Answers

• Where does Boston IVF appear in AI responses without converting presence into actual recommendations?
• Which platforms show the clearest gap between Boston IVF's visibility and its recommendation credit?
• How far behind the category leaders is Boston IVF in top-three placement?

Boston IVF's core problem is visibility without recommendation conversion. The brand appears in 21 qualified observations but receives only 12 valid recommendations, meaning nearly half of its AI presence does not translate into an actual recommendation. This pattern is most visible on Gemini, where Boston IVF appears twice but earns zero valid recommendation credit, and on Copilot, where the brand appears twice but receives only one recommendation at rank seven.

The gap between Boston IVF and the category leaders is substantial. CCRM Fertility holds 31.72% valid recommendation coverage on 105 valid recommendations, while Shady Grove Fertility holds 22.66% on 75 valid recommendations. Boston IVF's 12 valid recommendations place it well behind the leader tier, and its 0.60% top-three rate means the brand rarely appears among the first three options AI systems present to prospective patients.

Boston IVF also shows no presence on Perplexity in the September 2026 benchmark, despite that platform surfacing 14 qualified observations for the category. The brand's absence from Perplexity represents a clear platform gap, particularly given that competitors like RMA Network and CCRM Fertility both achieve 50% valid recommendation coverage on that platform.

Biggest Opportunity

Questions This Section Answers

• What is Boston IVF's clearest opportunity to convert its AI presence into stronger recommendation placement?
• Why does Boston IVF's ChatGPT presence leave it just outside the most visible recommendation tier?

Boston IVF's clearest opportunity is converting its ChatGPT presence into consistent top-three placement. The brand already achieves its strongest positive visibility and perfect sentiment on ChatGPT, yet none of its 4 valid recommendations on that platform reach the top three positions. Boston IVF's average recommended rank on ChatGPT is 4.25, meaning the brand is consistently mentioned but placed just outside the most visible recommendation tier. Closing that gap would move Boston IVF from a brand that AI systems acknowledge to one they actively shortlist.

Competitive Landscape

Questions This Section Answers

• Where does Boston IVF rank against its tracked competitors on valid recommendation coverage?
• Which brands command the strongest recommendation-stage positions in the IVF Clinics category?

CCRM Fertility, Shady Grove Fertility, and RMA Network hold the strongest recommendation-stage positions in the IVF Clinics category, with CCRM Fertility leading at 31.72% valid recommendation coverage. Boston IVF sits in the lower tier of the tracked competitor set, ahead of Extend Fertility and US Fertility but well behind the mid-field brands.

Average recommended rank covers rank-eligible recommendations only.

Boston IVF's 0.60% top-three rate is the second lowest among brands with any rank-eligible recommendations, and its average recommended rank of 4.33 reflects placement that consistently falls outside the most visible recommendation positions. The brand's sentiment score of 0.5714 is mid-pack, indicating that when Boston IVF is mentioned, the framing is generally positive but the brand is not being positioned as a leading choice.

Prompt Evidence

ChatGPT / Best IVF Clinics Discovery & Evaluation Prompt: "best ivf clinic" Result: Boston IVF appeared in the response with positive framing and received valid recommendation credit, though not within the top three positions.

Gemini / Best IVF Clinics Discovery & Evaluation Prompt: "ivf clinic near me" Result: Boston IVF appeared in the response but received no valid recommendation credit, surfacing as a reference rather than a recommended option.

Copilot / Best IVF Clinics Discovery & Evaluation Prompt: "top rated fertility clinic" Result: Boston IVF received a single valid recommendation at rank seven, placing the brand well outside the top-three tier where most patient selection occurs.

What CiteWorks Studio Would Do Next

Phase 1: AI Market Discovery Audit Map the specific prompts and surfaces where Boston IVF appears without recommendation credit, identifying which competitor captures the placement Boston IVF loses.

Phase 2: Recommendation Readiness Plan Strengthen the pages and content that AI systems currently retrieve when they mention Boston IVF, with priority on converting neutral references into positive recommendations.

Phase 3: Owned Answer Layer Buildout Develop authoritative content that answers high-intent fertility questions directly, giving AI systems clearer material to cite when recommending clinics.

Phase 4: Citation / Authority Layer Development Build the external citation footprint that supports Boston IVF's inclusion in AI-generated shortlists, focusing on the sources AI systems appear to trust in this category.

Phase 5: Monthly AI Visibility and Recommendation Tracking Track Boston IVF's presence, recommendation coverage, and placement across platforms monthly to measure whether the gap between mention and recommendation is closing.

Why This Matters

Questions This Section Answers

• Why does recommendation placement in AI responses shape which fertility clinics patients consider?
• What makes presence without recommendation an incomplete signal for Boston IVF?

AI-generated recommendations are becoming a primary discovery mechanism for patients researching fertility clinics. When a prospective patient asks an AI assistant which IVF clinic to consider, the brands that appear in the response and the order in which they appear shape the consideration set before the patient ever visits a website.

Boston IVF's current position shows that AI systems acknowledge the clinic but do not consistently recommend it. Presence without recommendation is an incomplete signal: it creates awareness without driving selection. The next move for Boston IVF is not broader visibility but targeted correction of the prompt, page, and citation layers that determine whether a mention becomes a recommendation.

Core Metrics

Sentiment Score

Questions This Section Answers

• How is net sentiment score calculated, and why does it matter for interpreting AI visibility?
• Why can raw mention counts mislead when evaluating a brand's AI presence?

Sentiment Score = (positive mentions × 1 + neutral mentions × 0 + negative mentions × -1) / total mentions

For Boston IVF, this calculation is (12 × 1 + 9 × 0 + 0 × -1) / 21, producing a net sentiment score of 0.5714.

This score matters because unclassified mention counts are misleading. A brand can appear frequently in AI responses while carrying mostly neutral or cautionary framing, which does not translate into patient selection. Share of voice is a diagnostic metric, not a business outcome. A positive recommendation, a neutral reference, and a competitor-displaced mention are not equal signals, and counting all mentions as wins produces a distorted view of AI visibility. Classified sentiment is required before any interpretation of AI visibility can support strategic decisions.

Sentiment by Platform

Methodology

1. This report is a benchmark-based analysis of Boston IVF's AI visibility and recommendation position within the IVF Clinics vertical, derived from the LLM Authority Index AI Market Discovery Index public dataset. It is not a client implementation case study.
2. The reporting window is September 2026, with comparative reference to the July 2026 baseline and August 2026 intermediate month where relevant.
3. Six AI surface families were tracked: ChatGPT, Copilot, Gemini, Perplexity, Google AI Mode, and Google AI Overviews.
4. The September 2026 benchmark began with 558 prompt-surface observations, of which 399 were unique questions and 481 were relevant to the IVF Clinics vertical. After qualification, 331 observations formed the public denominator for all brand-level metrics.
5. The competitor universe includes 10 tracked brands: CCRM Fertility, Shady Grove Fertility, RMA Network, Columbia University Fertility Center, Pacific Fertility Center, Kindbody, Spring Fertility, Boston IVF, Extend Fertility, and US Fertility.
6. All qualified observations in September 2026 fell into the Brand Recommendation buyer-intent class. The Pricing & Value and Multi-Brand Comparison clusters registered zero observations, meaning the public benchmark cannot currently answer questions about price positioning or direct head-to-head clinic comparisons.
7. Stage 0 extraction captured prompt-level observations including the query, AI surface, answer, brand outcome, recommendation placement, sentiment, and citations where exposed. Source presence is evidence about the information environment, not proof that a source caused a recommendation.
8. A mention is defined as any qualified observation where a tracked brand appears in an AI response, regardless of context or framing.
9. A valid recommendation is defined as a qualified observation where a brand receives a clear recommendation, distinct from a neutral reference, cautionary mention, or comparison anchor.
10. Brand-level percentages use the 331 qualified observations as the denominator, not the 558 raw prompt-surface observations.
11. Small-count brands carry wider relative uncertainty. Boston IVF's 12 valid recommendations and 21 mentions should be read as directional signals rather than definitive measurements.
12. Month-over-month movement identifies changes worth investigating but does not by itself establish the cause of those changes. Observed shifts may reflect changes in AI model behavior, prompt composition, or broader information dynamics.

Get Your AI Visibility Audit

The public benchmark shows where Boston IVF stands in AI-generated recommendations, but it does not explain why the brand appears without being recommended. A company-level AI visibility audit maps the specific prompts, surfaces, competitor displacements, and evidence sources that determine whether Boston IVF converts presence into recommendation. The benchmark frames the opportunity; a company-level analysis explains the mechanics.